Resmed has its origins in the 1980s, when Sydney sleep expert Dr Colin Sullivan converted a vacuum cleaner to deal with the ...

Medical device company ResMed (NYSE:RMD) announced better-than-expected revenue in Q4 CY2024, with sales up 10.3% year on ...

ResMed is an innovation machine. Our ongoing investments of 6% to 7% of revenues ... the world leader in providing facial interfaces in the field of sleep health and breathing health and healthcare ...

He also said the company had a solid base in machine learning and artificial intelligence, bolstered by billions of nights worth of sleep data. “We’ve launched a generative AI product into the market ...

ResMed’s competitors might be hamstrung by ... as we continue to educate people on the benefits of healthy sleep and breathing, with care delivered right in their own home.” ...

Q2 2025 Earnings Call Transcript January 30, 2025 ResMed Inc. beats earnings expectations. Reported EPS is $2.43, expectations were $2.32. Operator: Welcome to the Q2 Fiscal Year 2025 ResMed Earnings ...

The Sleep and Breathing Health segment ... its integrated care capabilities. ResMed is known to leverage trends such as artificial intelligence (AI) and machine learning to bolster its product ...

CEO Michael Farrell reported 10% global revenue growth, driven by demand across the sleep health, breathing health, and residential care software portfolios. Device sales, including AirSense 10 and ...

ResMed reported robust earnings for the second quarter of fiscal 2025, surpassing expectations and showcasing strong growth ...